Sponsor or institution
Clinical trials and research at Ryvu Therapeutics SA
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Ryvu Therapeutics SA that are recruiting, at sites in 5 countries (most in France (2), Poland (2), Spain (2)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Treatment for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
This study is testing a new treatment called MEN1703, alone and with another drug, to see if it helps people with aggressive B-cell non-Hodgkin lymphoma who haven't responded to other treatments.
-
Combining RVU120 with Venetoclax for treating relapsed or refractory AML
This study is testing a new combination of two drugs, RVU120 and venetoclax, to see if they can help adults with relapsed or hard-to-treat acute myeloid leukemia feel better after previous treatments didn't work.
Quick answers
How many clinical trials run by Ryvu Therapeutics SA are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in France (2 trials), Poland (2 trials), Spain (2 trials), United Kingdom (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.